Prosigna Competitors and Similar CompaniesClear all

Prosigna's competitors and similar companies include Aspira Women's Health, Arbor Vita, PFS Genomics and Provista Diagnostics.
Prosigna
Prosigna
Prosigna is a test for breast cancer developed by Veracyte to measure recurrence risk.
Aspira Women's Health
Aspira Women's Health
Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health.
Arbor Vita
Arbor Vita
Arbor Vita Corporation (AVC) is a biotech company developing cancer diagnostics.
PFS Genomics
PFS Genomics
PFS Genomics is a company providing a solution for personalizing breast cancer treatment.
Provista Diagnostics
Provista Diagnostics
Provista Diagnostics is a molecular diagnostics company providing tests to detect women’s cancer.
Founding Date
Founding Date
N/A
Founding Date
1993
Founding Date
1998
Founding Date
2015
Founding Date
2007
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
HQ
Locations
Austin, US HQ
Locations
Fremont, US HQ
Locations
Vancouver, CA HQ
Locations
Alpharetta, US HQ
Employees
Employees
N/A
Employees
4310% increase
Employees
24
Employees
1
Employees
9

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 84.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 34.5m
For sources of this data, please see the company profile

View Company Profiles

Aspira Women's Health
HQ
Austin, US
Employees
43↑ 10% increase

Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health.

View company
Arbor Vita
HQ
Fremont, US
Employees
24

Arbor Vita Corporation (AVC) is a biotech company developing cancer diagnostics.

View company
PFS Genomics
HQ
Vancouver, CA
Employees
1

PFS Genomics is a company providing a solution for personalizing breast cancer treatment.

View company
Provista Diagnostics
HQ
Alpharetta, US

Provista Diagnostics is a molecular diagnostics company providing tests to detect women’s cancer.

View company